1 – 10 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
SGLT2 Inhibitors in Patients with Urogenital Malformations and Urinary Diversions : Risks, Benefits, and Clinical Considerations
- Contribution to journal › Scientific review
-
Mark
Prostate-specific antigen levels at age 60 and lifetime risk of lethal prostate cancer
(2025) In Journal of the National Cancer Institute
- Contribution to journal › Article
-
Mark
Prostate-Specific Antigen Levels Among Participants Receiving Annual Testing
(2025) In JAMA Oncology
- Contribution to journal › Article
-
Mark
Magnetic resonance imaging for long-term active surveillance biopsy decision-making
- Contribution to journal › Article
-
Mark
Size-selective glomerular filtration as a hallmark of premature kidney ageing in nondiabetic individuals
- Contribution to journal › Article
-
Mark
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma
- Contribution to journal › Article
-
Mark
Gene and pathway analysis of genome-wide genetic associations of bladder cancer
- Contribution to journal › Article
-
Mark
Applicability of the European Association of Urology 2021 Prognostic Model for Non–muscle-invasive Bladder Cancer in a Swedish Population-based Cohort
- Contribution to journal › Letter
-
Mark
Prostate cancer diagnostics: evolution over 30 years and the impact of education level – a prospective population-based study
- Contribution to journal › Article
-
Mark
Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer : A Nationwide Population-based Study
- Contribution to journal › Article
